TAKEDA PHARMACEUTICALS USA, INC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for TAKEDA PHARMACEUTICALS USA, INC

Sort by

Viewing results 1‒25 of 193

Pharmaceuticals sector
Merck in talks over $40bn deal for cancer biotech SeaGen
...SeaGen also recently signed a partnership with French drugmaker Sanofi and has agreements with Takeda and Bristol Myers Squibb among others. SeaGen declined to comment....
July 7, 2022
Japanese politics & policy
Japan depends on overseas vaccines due to 30 years of inaction
...Takeda Pharmaceutical has no plans to seek approval in Japan for its dengue fever vaccine, nor does Mitsubishi Tanabe Pharma for an inoculation derived from a tobacco leaf plant....
May 17, 2021
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
Anjana Ahuja
Should we take a chance and divert early booster shots to the unprotected?
...“I feel very strongly that we should get as many shots in arms as possible, right away,” Mr Gottlieb told USA Today last week. “The reality is that one dose is partially protective....
December 15, 2020
Inside BusinessKana Inagaki
Crisis pushes Japan Inc to bury old rivalries
...Takeda Pharmaceuticals, which closed a £46bn deal for Irish drugmaker Shire last year, is in talks to sell its domestic over-the counter medicine business for several billion dollars to reduce its debt....
July 21, 2020
News in-depthNikkei Asia
What Japan Inc really thinks about Carlos Ghosn, Nissan’s maverick saviour Premium content
...Some, such as Christophe Weber at Takeda Pharmaceutical and Sarah Casanova at McDonald’s Japan, are regarded as successful....
January 19, 2020
Walgreens Boots Alliance Inc
Walgreens Boots sticks with guidance as US pharma sales improve
...In particular, WBA pointed to a 2.3 per cent year-on-year rise in sales at its main Retail Pharmacy USA division, with a rise in pharmacy sales offsetting declining retail sales....
June 27, 2019
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Novartis AG
Head of Novartis generic drugs business steps down
...In September last year, Novartis said it would sell parts of the Sandoz US business to Aurobindo Pharma USA to focus on “higher growth areas”....
March 14, 2019
Mergers & Acquisitions
Wall St set for $1bn fee bonanza from pharma mega-deal
...The overall costs on the deal rival the near $1bn that Japanese pharmaceutical group Takeda spent on its purchase of Shire last year, although it is dwarfed by the roughly $2bn of expenses and fees paid...
February 3, 2019
UK small companies
Takeda chief seeks to allay £46bn Shire bid concerns
...Christophe Weber is racing to win backing for Japan’s largest-ever outbound takeover, which would catapult the Osaka-based drugmaker into the ranks of the world’s biggest pharmaceutical companies....
June 27, 2018
European companies
Novartis offloads part of Sandoz generics business in US
...On Thursday, Novartis said it would sell portions of the Sandoz US portfolio to Aurobindo Pharma USA in order to focus on “higher growth areas”....
September 6, 2018
European companies
Shire board recommends £46bn takeover by Takeda
...If completed, it would rank as one of the industry’s biggest, and mark a significant moment in the evolution of Japan Inc as a global dealmaker....
May 8, 2018
US & Canadian companies
Shire rejects £42.4bn Takeda offer as Allergan rules itself out
...Last year, Takeda acquired US oncology group Ariad Pharmaceuticals for $5.2bn and it later tried to acquire Valeant, the Canadian drugmaker, for around $10bn. but the talks collapsed over price....
April 19, 2018
News in-depthWeek in Review
Week in review, March 31
...Others focused on the significance of Takeda’s move for its country’s pharmaceuticals industry....
March 30, 2018
Sport
Takeover battle looms as Allergan considers bid for Shire
...Shire said on Thursday that the £42.4bn bid from Takeda — the third offer from the Japanese company — still undervalued the group....
April 19, 2018
News in-depthCorporate governance
Leading critic of Japan Inc puts funds on alert
...Allegiants underlie Takeda confidence As Christophe Weber, the chief executive of Takeda Pharmaceutical, met with US investors last week, he was brimming with confidence that he would win the requisite...
June 11, 2018
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
US & Canadian companies
Japan’s Renesas to acquire US rival IDT in $7.2bn deal
...The latest acquisition contributes to a record year for Japanese outbound deals, led by Takeda Pharmaceutical’s £46bn agreement to buy Irish drugmaker Shire in April....
September 11, 2018
News in-depthThe Big Read
Media: US ‘ghost newspapers’ struggle for life
...“Anyone with the appetite and dollars to buy can, whether it’s a Patrick Soon-Shiong [the pharmaceuticals billionaire who owns the LA Times] or an Alden.”...
February 25, 2019
Due Diligence
Will (Big) Blue + Red (Hat) = green for IBM shareholders? Premium content
...While the Recordati family sold a majority of their shares in their pharmaceuticals company to the US private equity group CVC in July....
October 30, 2018
Mergers & Acquisitions
Praxair sells $6bn in European assets to Japan’s Taiyo
...The combined value of those deals — which include Takeda Pharmaceutical’s ¥7tn planned takeover of Shire — was around ¥11.7tn....
July 5, 2018
LexEuropean companies
Shire/Allergan: too many wrinkles Premium content
...Apart from adding negotiating leverage with Takeda and possibly another larger pharma bidder, an Allergan offer does not appeal....
April 19, 2018
US & Canadian companies
Pfizer says it is not looking for a mega-deal
...Last week, Japan’s Takeda Pharmaceutical reached a preliminary agreement to buy Irish drugmaker Shire for about £46bn in a deal that bankers predicted was a portent of things to come....
May 1, 2018
The Big ReadJapanese business & finance
Why Japan Inc is gambling on M&A growth
...Takeda/Shire $65bn APRIL 2018 Takeda Pharmaceutical reaches a preliminary agreement to buy Irish drugmaker Shire for $65bn in a deal that could spark more M&A in the sector Yet as industries consolidate...
April 30, 2018
News in-depthCurrencies
Global M&A activity hits new high
...Corporate giants including US cable group Comcast, wireless provider T-Mobile and Japan’s pharmaceutical maker Takeda reached for M&A to head off competitive threats and expand their businesses....
September 28, 2018
News in-depthBanks
Record ‘megadeals’ push global takeovers beyond $1.2tn
...In the latest sign of how eager boardrooms are sparking a record number of “megadeals”, Japan’s top drugmaker Takeda revealed it was weighing a $40bn takeover of Irish rival Shire....
March 29, 2018
Pharmaceuticals sector
Mylan drops as AGs look to expand generic drug-pricing lawsuit
...The companies now under investigation are: Heritage Pharmaceuticals, Inc.; Aurobindo Pharma USA, Inc.; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA;...
October 31, 2017

Previous pagePage 1 of 8Next page